Literature DB >> 9551995

Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice.

N V Contractor1, H Bassiri, T Reya, A Y Park, D C Baumgart, M A Wasik, S G Emerson, S R Carding.   

Abstract

IL-2-deficient (IL-2(-/-)) mice develop disorders of the hemopoietic and immune systems characterized by anemia, lymphocytic hyperplasia, and colitis. The mechanisms responsible for these abnormalities remain unclear. To investigate the underlying basis of autoimmunity, the particular role of commensal gut flora in the initiation of colitis, and the role of IL-2 in the development of intestinal intraepithelial lymphocytes (iIEL), we evaluated IL-2(-/-) mice reared and maintained under gnotobiotic (germfree) conditions. By 8 wk of age, 80% (20 of 25) of germfree IL-2(-/-) mice show signs of disease, including anemia, disturbances in bone marrow hemopoietic cells, lymphocytic hyperplasia, and generalized autoimmunity, similar to those seen in specific pathogen-free (SPF) IL-2(-/-) mice. In striking contrast to SPF IL-2(-/-) mice, germfree IL-2(-/-) mice do not develop colitis. However, the numbers of gammadelta+ and TCR alphabeta+ CD8 alphaalpha+ iIELs are reduced, and in lethally irradiated SPF IL-2(+/+) mice, reconstituted with IL-2(-/-) bone marrow TCR gammadelta+ iIELs fail to develop, consistent with an important role of IL-2/IL-2R signaling in the development of gammadelta iIELs. Consequently, our findings demonstrate that the colitis seen in SPF IL-2(-/-) mice depends upon the presence of intestinal bacterial flora and that environmental Ags are not responsible for the anemia and extraintestinal lymphoid hyperplasia that occur in IL-2(-/-) mice. Thus, germfree IL-2(-/-) mice represent a unique system in which the role of IL-2 deficiency in hemopoietic and immune system disorders can be investigated in dissociation from complications that may arise due to colitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551995

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.

Authors:  W Strober; K Nakamura; A Kitani
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine.

Authors:  Amlan Biswas; Jeanette Wilmanski; Huamei Forsman; Tomas Hrncir; Liming Hao; Helena Tlaskalova-Hogenova; Koichi S Kobayashi
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

3.  Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation.

Authors:  Mélanie G Gareau; Jennifer Jury; Glenda MacQueen; Philip M Sherman; Mary H Perdue
Journal:  Gut       Date:  2007-03-05       Impact factor: 23.059

Review 4.  Immunopathogenesis of inflammatory bowel disease.

Authors:  David Q Shih; Stephan R Targan
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 5.  Autoantibodies and an immune-based rat model of inflammatory bowel disease.

Authors:  Hadi Esmaily; Yara Sanei; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  Characterization of colonic dendritic cells in normal and colitic mice.

Authors:  Sheena M Cruickshank; Nicholas R English; Peter J Felsburg; Simon R Carding
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 7.  The gut-eye-lacrimal gland-microbiome axis in Sjögren Syndrome.

Authors:  Claudia M Trujillo-Vargas; Laura Schaefer; Jehan Alam; Stephen C Pflugfelder; Robert A Britton; Cintia S de Paiva
Journal:  Ocul Surf       Date:  2019-10-20       Impact factor: 5.033

8.  Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease.

Authors:  M Zareie; P K Singh; E J Irvine; P M Sherman; D M McKay; M H Perdue
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 9.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

Review 10.  T cells and intestinal commensal bacteria--ignorance, rejection, and acceptance.

Authors:  Jiani N Chai; You W Zhou; Chyi-Song Hsieh
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.